Pilot Studies Program

$74,858P60FY2015AANIH

University Of Connecticut Sch Of Med/Dnt, Farmington CT

Investigators

Linked publications, trials & patents

Paper 39555136 Paper 38684046 Paper 38225874 Paper 37004447 Paper 36971759 Paper 36107642 Paper 35728089 Paper 35229945 Paper 34712519 Paper 34545657 Paper 34225029 Paper 34120366 Paper 34049101 Paper 33818193 Paper 33793278 Paper 33138928 Paper 33029895 Paper 32911355 Paper 32745946 Paper 32701168 Paper 32622025 Paper 32574382 Paper 32039621 Paper 31955720 Paper 31931271 Paper 31442882 Paper 31436886 Paper 31343197 Paper 31343196 Paper 30959414 Paper 30930609 Paper 30862775 Paper 30710610 Paper 30537098 Paper 30308286 Paper 30307258 Paper 30265039 Paper 30170301 Paper 29777461 Paper 29734827 Paper 29723083 Paper 29461070 Paper 29423990 Paper 29289852 Paper 29156239 Paper 29129191 Paper 28921996 Paper 28745446 Paper 28728460 Paper 28709081 Paper 28672076 Paper 28639817 Paper 28639812 Paper 28630458 Paper 28476266 Paper 28042525 Paper 27915167 Paper 27896905 Paper 27750317 Paper 27746057 Paper 27635675 Paper 27613901 Paper 27536011 Paper 27536009 Paper 27492676 Paper 27449226 Paper 27398781 Paper 27196697 Paper 27051333 Paper 27020748 Paper 26894560 Paper 26894551 Paper 26891181 Paper 26885470 Paper 26817621 Paper 26812684 Paper 26716877 Paper 26716875 Paper 26691066 Paper 26682582 Paper 26669531 Paper 26589363 Paper 26580209 Paper 26408026 Paper 26388585 Paper 26250693 Paper 26244381 Paper 26237326 Paper 26232136 Paper 26216590 Paper 26203061 Paper 26184649 Trial NCT02499913 Trial NCT02143037 Trial NCT01758523 Trial NCT01262287 Trial NCT00732342 Trial NCT00626925 Patent 6541478 Patent 6004970

Abstract

The Pilot Studies Program continues to play a crucial role in promoting the UCONN ARC'S vitality and growth. During the past 5 years, several innovative studies including: (1) microRNA regulation of HTR1B gene expression; (2) exercise as a behavioral intervention for hazardous drinking in college students; (3) examining genes that may affect problem drinking and obesity risk; and (4) examining the safety and efficacy of dutasteride as a treatment for heavy drinking were supported. One of these projects inspired a major component of this Center renewal application. Others have led, or are likely to lead, to applications for other types of extramural support. The Pilot Studies Program will continue to be managed by the PI and Executive Committee in consultation with internal and external advisors. Following an open call for proposals, applications will be reviewed to: (1) judge scientific merit; (2) improve the quality of the research through feedback, revision, and mentorship (if needed); (3) create a system whereby resources are allocated fairiy and equitably; and (4) ensure that the research meets ethical standards. Several projects are proposed. The first project will examine dermal fibroblasts, sampled from alcoholdependent and non-dependent subjects that are reprogrammed into induced pluripotent stem (iPS) cells and differentiated into neurons. The goal is to detect changes in NMDA receptor and GABAergic signaling in response to acute and chronic alcohol exposure. A second project will survey the fidelity and acceptance of Contingency Management for alcohol dependence as it is disseminated in clinical settings throughout the VA health care system. The third project will take advantage of the screening, brief intervention and referral to treatment (SBIRT) initiative mandated by JCAHO and CMS for hospitals in New England, including UCHC. This study will develop process measures needed to evaluate the mechanisms of change attributable to factors other than the intervention. Projects proposed for the out years will be designed around new alcohol research collaborations being developed with the Connecticut Department of Corrections, the Jackson Laboratories' personalized medicine research facility now under construction on our campus.

View original record on NIH RePORTER →